Among 46 near full length HIV type 1 genome sequences from Rakai District, Uganda, subtype D and AD recombinants predominate

AIDS Research and Human Retroviruses

Volumn 18, Issue 17, 2002, Pages 1281-1290

  Harris, Matthew E ^a   Serwadda, David ^b   Sewankambo, Nelson ^b   Kim, Bohye ^c   Kigozi, Godfrey ^b   Kiwanuka, Noah ^b   Phillips, James B ^c   Wabwire, Fred ^b   Meehen, Mary ^d   Lutalo, Tom ^e   Lane, James R ^c   Merling, Randall ^c   Gray, Ron ^f   Wawer, Maria ^d   Birx, Deborah L ^a   Robb, Merlin L ^a   McCutchan, Francine E ^c  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^f JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AMPLICON; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE MAPPING; GENE SEQUENCE; GENOME; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MALE; MONONUCLEAR CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UGANDA; VIRUS CHARACTERIZATION; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TYPING;

ADOLESCENT; ADULT; BASE SEQUENCE; DNA, VIRAL; FEMALE; GENOME, VIRAL; HIV-1; HUMANS; MALE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RECOMBINATION, GENETIC; UGANDA;

EID: 0036941595     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922202320886325     Document Type: Article

References (74)

1. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal: A reference guide to HIV-1 classification. In: Human Retroviruses and AIDS 1999: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Kuiken C, Foley B, Hahn B, et al., eds.). Theorectical Biology and Biophysics Group, Los Alamo National Laboratory, Los Alamos, NM, 1999, pp. 492-505.
2. McCutchan FE: Global Diversity in HIV. In: The Evolution of HIV (Crandall KA, ed.). Johns Hopkins University Press, Baltimore, MD, 1999, pp. 41-101.
3. Peeters M and Sharp PM: Genetic diversity of HIV-1: The moving target. AIDS 2000;14:S129-140.
4. McCutchan FE: Understanding the genetic diversity of HIV-1. AIDS 2000;14:S31-44.
5. Robertson DL, Anderson JP, Bradac JA, et al.: HIV-1 nomenclature proposal. Science 2000;288:55-56.
6. Robertson DL, Sharp PM, McCutchan FE, and Hahn BH: Recombination in HIV-1. Nature 1995;374:124-126.
7. Rambaut A, Robertson DL, Pybus OG, Peeters M, and Holmes EC: Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature 2001;410:1047-1048.
8. Gao F, Bailes E, Robertson DL, et al.: Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature 1999;397:436-441.
9. Hahn BH, Shaw GM, De Cock KM, and Sharp PM: AIDS as a zoonosis: Scientific and public health implications. Science 2000;287:607-614.
10. Carr JK, Salminen MO, Koch C, et al.: Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996;70:5935-5943.
11. Gao F, Robertson DL, Morrison SG, et al.: The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996;70:7013-7029.
12. Korber B, Muldoon M, Theiler J, et al.: Timing the ancestor of the HIV-1 pandemic strains. Science 2000;288:1789-1796.
13. McCutchan FE, Artenstein AW, Sanders-Buell E, et al.: Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol 1996;70:3331-3338.
14. Sharp PM: Origins of human virus diversity. Cell 2002;108:305-312.
15. Kessler JA, 2nd, McKenna PM, Emini EA, et al.: Recombinant human monoclonal antibody IgG1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates. AIDS Res Hum Retroviruses 1997;13:575-582.
16. Moore JP, Parren PW, and Burton DR: Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development. J Virol 2001;75:5721-5729.
17. van der Groen G, Nyambi PN, Beirnaert E, et al.: Genetic variation of HIV type 1: Relevance of interclade variation to vaccine development. AIDS Res Hum Retroviruses 1998;14(Suppl. 3):S211-221.
18. Ferrari G, Humphrey W, McElrath MJ, et al.: Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci USA 1997;94:1396-1401.
19. Cao H, Mani I, Vincent R, et al.: Cellular immunity to human immunodeficiency virus type 1 (HIV-1) clades: Relevance to HIV-1 vaccine trials in Uganda. J Infect Dis 2000;182:1350-1356.
20. Cao H, Kanki P, Sankale JL, et al.: Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: Implications for vaccine development. J Virol 1997;71:8615-8623.
21. Ferrari G, Kostyu DD, Cox J, et al.: Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines. AIDS Res Hum Retroviruses 2000;16:1433-1443.
22. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: Genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses 1994;10:1327-1343.
23. Bachmann MH, Delwart EL, Shpaer EG, Lingenfelter P, Singal R, and Mullins JI: Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses 1994;10:1345-1353.
24. Becker-Pergola G, Mellquist JL, Guay L, et al.: Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women. AIDS Res Hum Retroviruses 2000;16:1099-1104.
25. Brennan CA, Lund JK, Golden A, et al.: Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda. AIDS 1997;11:1823-1832.
26. Bruce C, Clegg C, Featherstone A, et al.: Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda. AIDS Res Hum Retroviruses 1994;10:1543-1550.
27. Douglas NW, Knight AI, Hayhurst A, Barrett WY, Kevany M J, and Daniels RS: An efficient method for the rescue and analysis of functional HIV-1 env genes: Evidence for recombination in the vicinity of the tat/rev splice site. AIDS 1996;10:39-46.
28. Downing R, Pieniazek D, Hu DJ, et al.: Genetic characterization and phylogenetic analysis of HIV-1 subtype C from Uganda. AIDS Res Hum Retroviruses 2000;16:815-819.
29. Hu DJ, Baggs J, Downing RG, et al.: Predominance of HIV-1 subtype A and D infections in Uganda. Emerg Infect Dis 2000;6:609-615.
30. Kaleebu P, Bobkov A, Cheingsong-Popov R, Bieniasz P, Garaev M, and Weber J: Identification of HIV-1 subtype G from Uganda. AIDS Res Hum Retroviruses 1995;11:657-659.
31. Kaleebu P, Yirrell D, French N, et al.: An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in Uganda. AIDS Res Hum Retroviruses 2000;16:621-625.
32. Kaleebu P, Ross A, Morgan D, et al.: Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS 2001;15:293-299.
33. Luo CC, Downing RG, Dela Torre N, et al.: The development and evaluation of a probe hybridization method for subtyping HIV type 1 infection in Uganda. AIDS Res Hum Retroviruses 1998;14:691-694.
34. Rayfield MA, Downing RG, Baggs J, et al.: A molecular epidemiologic survey of HIV in Uganda. HIV Variant Working Group. AIDS 1998;12:521-527.
35. Smith JD, Bruce CB, Featherstone AS, et al.: Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994;10:577-583.
36. Buonaguro L, Del Guadio E, Monaco M, et al.: Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program. J Virol 1995;69:7971-7981.
37. Kaleebu P, Whitworth J, Hamilton L, et al.: Molecular epidemiology of HIV type 1 in a rural community in southwest Uganda. AIDS Res Hum Retroviruses 2000;16:393-401.
38. Mracna M, Becker-Pergola G, Dileanis J, et al.: Performance of applied biosystems ViroSeq HIV-1 genotyping system for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda. J Clin Microbiol 2001;39:4323-4327.
39. Yirrell DL, Kaleebu P, Morgan D, et al.: Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda. AIDS 2002;16:279-286.
40. Eshleman SH, Gonzales MJ, Becker-Pergola G, et al.: Identification of Ugandan HIV type 1 variants with unique patterns of recombination in pol involving subtypes A and D. AIDS Res Hum Retroviruses 2002;18:507-511.
41. Cornelissen M, Kampinga G, Zorgdrager F, and Goudsmit J: Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization. J Virol 1996;70:8209-8212.
42. Wawer MJ, Sewankambo NK, Serwadda D, et al.: Control of sexually transmitted diseases for AIDS prevention in Uganda: A randomised community trial. Rakai Project Study Group. Lancet 1999;353:525-535.
43. Lane JR: Isolation and expansion of HIV from cells and body fluids by coculture. In: Methods in Molecular Medicine, Vol. 17: HIV Protocols (Michael N and Kim J, eds.). Humana Press Inc., Totowa, NJ, 1999, pp. 3-10.
44. Burke DS, Fowler AK, Redfield RR, Dilworth S, and ester CN: Isolation of HIV-1 from the blood of seropositive adults: Patient stage of illness and sample inoculum size are major determinants of a positive culture. The Walter Reed Retroviral Research Group. J Acquir Immune Defic Syndr 1990;3:1159-1167.
45. Salminen MO, Koch C, Sanders-Buell E, et al.: Recovery of virtually full-length HIV-1 provirus of diverse subtypes from primary virus cultures using the polymerase chain reaction. Virology 1995;213:80-86.
46. Carr JK, Laukkanen T, Salminen MO, et al.: Characterization of subtype A HIV-1 from Africa by full genome sequencing. AIDS 1999;13:1819-1826.
47. Salminen MO, Ehrenberg PK, Mascola JR, et al.: Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reaction. Virology 2000;278:103-110.
48. Felsenstein J: PHYLIP (Phylogeny Inference Package), 3.52c. Department of Genetics, University of Washington, Seattle, WA, 1992.
49. Salminen MO, Carr JK, Burke DS, and McCutchan FE: Identification of breakpoints in intergenotypic recombinants of HIV type 1 by bootscanning. AIDS Res Hum Retroviruses 1995;11:1423-1425.
50. Maciukenas S: Treetool, 2.0.2. Ribosomal DNA Database Project, University of Illinois Board of Trustees, Urbana, IL, 1994.
51. Hillis D and Bull J: An empirical test of bootstrapping as a method for assessing confidence in phylogenetic trees. Syst Biol 1993;42:182-192.
52. Carr JK, Foley B, Leitner T, Salminen M, Korber B, and McCutchan F: Reference sequences representing the principal genetic diversity of HIV-1 in the pandemic. In: Human Retroviruses and AIDS 1998: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Korber B, Kuiken C, Foley B, et al., eds.). Theorectical Biology and Biophysics Group, Los Alamo National Laboratory, Los Alamos, NM, 1998, pp. III10-III19.
53. Rose PP and Korber BT: Detecting hypermutations in viral sequences with an emphasis on G → A hypermutation. Bioinformatics 2000;16:400-401.
54. Janini M, Rogers M, Birx DR, and McCutchan FE: Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells. J Virol 2001;75:7973-7986.
55. Dowling W, Kim B, Mason CJ, et al.: Forty-one near full length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS 2002;16:1809-1820.
56. Hoelscher M, Kim B, Maboko L, et al.: High proportion of unrelated HIV-1 intersubtype recombinants in the Mbeya region of southwest Tanzania. AIDS 2001;15:1461-1470.
57. Sanchez-Palomino S, Dopazo J, Olivares I, Martin MJ, and Lopez-Galindez C: Primary genetic characterization of HIV-1 isolates from WHO-sponsored vaccine evaluation sites by the RNase-A mismatch method. Virus Res 1995;39:251-259.
58. Louwagie J, Janssens W, Mascola J, et al.: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
59. Koulinska IN, Ndung'u T, Mwakagile D, et al.: A new human immunodeficiency virus type 1 circulating recombinant form from Tanzania. AIDS Res Hum Retrovimses 2001;17:423-431.
60. Louwagie J, McCutchan FE, Peeters M, et al.: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993;7:769-780.
61. Abimiku AG, Stem TL, Zwandor A, et al.: Subgroup G HIV type 1 isolates from Nigeria. AIDS Res Hum Retroviruses 1994;10:1581-1583.
62. Janssens W, Heyndrickx L, Fransen K, et al.: Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retrovimses 1994;10:877-879.
63. De Baar MP, De Ronde A, Berkhout B, et al.: Subtype-specific sequence variation of the HIV type 1 long terminal repeat and primerbinding site. AIDS Res Hum Retrovimses 2000;16:499-504.
64. McCutchan FE, Ungar BL, Hegerich P, et al.: Genetic analysis of HIV-1 isolates from Zambia and an expanded phylogenetic tree for HIV-1. J Acquir Immune Defic Syndr 1992;5:441-449.
65. Ping LH, Nelson JA, Hoffman IF, et al.: Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: Underrepresentation of X4 variants. J Virol 1999;73:6271-6281.
66. Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, and Essex M: Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology 1999;254:220-225.
67. Zwart G, Wolfs TF, Bookelman R, et al.: Greater diversity of the HIV-1 V3 neutralization domain in Tanzania compared with The Netherlands: Serological and genetic analysis. AIDS 1993;7:467-474.
68. Siwka W, Schwinn A, Baczko K, et al.: vpu and env sequence variability of HIV-1 isolates from Tanzania. AIDS Res Hum Retroviruses 1994;10:1753-1754.
69. Lyamuya E, Olausson-Hansson E, Albert J, Mhalu F, and Biberfeld G: Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D. J Clin Virol 2000;17:57-63.
70. Robbins KE, Bandea CI, Levin A, et al.: Genetic variability of human immunodeficiency virus type 1 in rural northwest Tanzania. AIDS Res Hum Retroviruses 1996;12:1389-1391.
71. Renjifo B, Gilbert P, Chaplin B, et al.: Emerging recombinant human immunodeficiency viruses: Uneven representation of the envelope V3 region. AIDS 1999;13:1613-1621.
72. Holm-Hansen C, Ayehunie S, Johansson B, Nkya W, Shao J, and Haukenes G: HIV-1 proviral DNA sequences of env gp41 PCR amplificates from Tanzania. APMIS 1996;104:459-464.
73. Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, and Essex M: Diversity of the HIV-1 long terminal repeat following mother-to-child transmission. Virology 2000;274:402-411.
74. Carr JK, Salminen MO, Albert J, et al.: Full genome sequences of human immunodeficiency virus type 1 subtypes G and A/G inter-subtype recombinants. Virology 1998;247:22-31.